Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-24 @ 9:56 PM
NCT ID:
NCT01671332
Eligibility Criteria:
Inclusion Criteria:
* Pathologically proven diagnosis of non-small cell lung cancer
* Documented disease progression after first-line chemotherapy for non-small cell lung cancer
* Stable and treated CNS metastasis is allowed
* Radiation must be completed at least 2 weeks prior to starting protocol treatment
* Major surgery must be completed at least 4 weeks prior to starting protocol treatment
* ECOG performance status 0-2
* Sexually active patients must use adequate contraception
* Adequate bone marrow function
* Adequate renal function
* Adequate liver function
Exclusion Criteria:
* Severe hypersensitivity reaction to docetaxel
* Pre-existing grade 3 or 4 neuropathy
* Women who are pregnant or breastfeeding
* Uncontrolled intercurrent illness
* Receipt of 3 or more prior chemotherapy regimens
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01671332
Study Brief:
Protocol Section:
NCT01671332